n,n-dimethylarginine has been researched along with Glioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boult, JK; Jamin, Y; Leiper, JM; Robinson, SP; Walker-Samuel, S; Whitley, GS | 1 |
| Peng, XZ; Tan, XC; Wang, S; Yang, B; Yin, B | 1 |
2 other study(ies) available for n,n-dimethylarginine and Glioma
| Article | Year |
|---|---|
Active site mutant dimethylarginine dimethylaminohydrolase 1 expression confers an intermediate tumour phenotype in C6 gliomas.
Topics: Amidohydrolases; Animals; Arginine; Catalytic Domain; Female; Glioma; Magnetic Resonance Imaging; Mice; Mice, Nude; Microscopy, Fluorescence; Mutation; Neoplasm Transplantation; Neovascularization, Pathologic; Phenotype; Rats; Transplantation, Heterologous; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2011 |
Screening of substrates of protein arginine methyltransferase 1 in glioma.
Topics: Arginine; Cell Line, Tumor; Chromatography, Liquid; Glioma; Humans; Immunoprecipitation; Protein-Arginine N-Methyltransferases; Repressor Proteins; Substrate Specificity; Tandem Mass Spectrometry | 2012 |